NAD+ and metabolic

1 paper in the library, strongest Preliminary.

Graded Preliminary · Cell studies with mouse, pig, and non-human primate models, yet the mechanism and the combined treatment have not been tested in people.

Papers 1

Why Low NAD+ May Push Insulin-Making Cells Into Self-Inflicted InflammationPreliminary2026Cell death and differentiationIn cells and animals, oxidative stress drained NAD+ inside the insulin-producing cells of the pancreas, flipping a chemical switch that set off inflammation from within. Topping up NAD+ with NMN calmed that inflammation, and combining it with a second blocker worked better than either alone. The work spanned mice, pigs, and monkeys, so it's mechanism-level research, not a human result. For anyone curious about NAD+ boosters, this hints at why they get studied for metabolic health.

How this map is computed

A mark's size is the number of papers we hold on that pairing. It is a count, not a weighting by study design or sample size.

The fill shows the strongest grade in the cell. One Strong paper among four Preliminary ones still fills it dark, so open the cell to see the rest.

Grades and verdicts are assigned by a named person, never by counting.

An empty cell is a finding: nobody in our library has run that trial yet.

Back to the evidence map